{
    "code": "02007013",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02007013",
    "time": "2020-02-25 08:55:04",
    "許可證字號": "衛署藥輸字第007013號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/03\/17",
    "發證日期": "69\/03\/17",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200701301",
    "中文品名": "&quot;施福&quot; 四硝酸戊赤絲藻醇２０％",
    "英文品名": "PENTAERYTHRITE TETRANITRATE\/LACTOSE 20\/80%",
    "適應症": "冠狀動脈擴張劑",
    "劑型": "040（粉）",
    "包裝": "1,5,10,25,50公斤裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PENTAERYTHRITOL TETRANITRATE (PENTHROL)",
    "限制項目": "02輸　入",
    "申請商名稱": "0801701100  東信化學藥品有限公司",
    "申請商地址": "台北市吉林路４５號６樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCH0072000  DOTTIKON EXCLUSIVE SYNTHESIS AG",
            "製造廠廠址": "HEMBRUNNSTRASSE 17, CH-5605 DOTTIKON, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        }
    ],
    "CCC號列": "30039099905 其他醫藥製劑（不包括第３００２、３００５或３００６節所列者），包含兩種或以上之成分業經混合供治療或預防疾病之用，不具有劑量或零售包裝式樣者Other medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2412200610",
            "成分名稱": "PENTAERYTHRITOL TETRANITRATE (PENTHROL)",
            "含量描述": "Pentaerythrite Tetranitrate\/Lactose 20\/80% contains not less than 18.5% and not more than 21.5% of C5H8N4O12, calculated on the dry basis.",
            "含量": "0.0000000000",
            "單位": "%"
        }
    ]
}